TNFRSF17 and myasthenia gravis: We reported here chimeric antigen receptor (CAR) T cells targeting B-cell maturation antigen (BCMA) in two patients with highly relapsed and refractory myasthenia gravis (MG) (one with AChR-IgG, and one with Musk-IgG).